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ABSTRACT
Methods to Stop Caffeine Use and Minimize Caffeine Withdrawal Symptoms
in the State of Caffeine Dependence: A Literature Review
Morgan Behling
College of Nursing, BYU
Master of Science
Caffeine is the most consumed psychoactive drug in the world and those who consume it
frequently become dependent. Even if individuals desire to quit caffeine, they may not be able to
due to withdrawal side effects, or a lack of knowledge of how to quit. Harmful effects of longterm caffeine consumption include fatigue, irritability, headaches, nausea, and depression. The
goal of this literature review was to explore current evidence on different methods to quit or
reduce caffeine use and minimize caffeine withdrawal effects in those who are dependent. A
literature review of studies from 2014 to 2020 was conducted using the databases CINAHL,
PsychInfo and Medline. Using a gradual caffeine dose taper is successful in helping people quit
caffeine or reducing caffeine intake and keeping a journal of caffeine intake is a useful tool to
promote long-term cessation of caffeine consumption. Exercising for 20 minutes a day helps
combat withdrawal effect, by positively increasing mood and alertness. Professional counseling
has proven effective in assisting with caffeine withdrawal and providing individuals with
information about caffeine may assist in both reducing or stopping caffeine intake. Nurse
practitioners should assess patients for caffeine use and desire to reduce caffeine consumption.
Strategies identified in this literature review may be helpful in assisting patients quit or reduce
caffeine intake while minimizing withdrawal effects.
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Methods to Stop Caffeine Use and Minimize Caffeine Withdrawal Symptoms
in the State of Caffeine Dependence: A Literature Review
Introduction
Caffeine is the most consumed psychoactive drug in the world. In America, 87% of
adults and children regularly consume beverages and foods containing caffeine (Ferre, 2016).
With how prevalent caffeine use is, nurse practitioners will frequently care for patients who
consume caffeine. Short-term benefits of caffeine consumption include increased alertness,
concentration, and improved mood (Nehlig, 2015). Patients report caffeine consumption for
reasons such as increasing energy for sports or exercise, increasing their ability to focus,
increasing alertness, or simply because they like how it makes them feel (Scuri et. al, 2018). Due
to its benefits, some patients will frequently consume caffeine, and become dependent upon it in
order to function normally. Caffeine dependence is associated with decreased sleep quality,
daytime drowsiness, headaches, and psychological distress (Ogeil & Phillips, 2015).
Caffeine dependence is a worldwide issue. In the International Statistical Classification of
Diseases and Related Health Problems, the World Health Organization (WHO) categorizes
caffeine as a psychostimulant that produces withdrawal and dependence disorders (Budney &
Emond, 2014). In addition, the fifth edition of the Diagnostic and Statistical Manual of Mental
Disorders identifies caffeine withdrawal as a formal disorder (Budney & Emond, 2014).
Caffeine withdrawal symptoms include headache, fatigue, low energy, irritability,
anxiety, poor concentration, depressed mood, and tremors (Ogeil & Phillips, 2015). Many
patients report these negative withdrawal symptoms as the primary reason they continue caffeine
intake, even when they have a desire to quit. The purpose of this literature review is to examine
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different methods for quitting or decreasing caffeine intake and managing caffeine withdrawal
symptoms.
Background
Caffeine works by increasing and enhancing dopamine signaling in the brain through
increased dopamine receptor availability. Other stimulant drugs such as cocaine function
similarly. Dopamine controls various physiological functions throughout the body and in the
brain by acting on receptors D1, D2, D3, D4, and D5 (Mishra et al., 2018). These receptors help
control and regulate human motivation, concentration, psychomotor speed, concentration, and
the ability to experience pleasure (Dunlop & Nemeroff, 2007).
In addition, dopamine is the primary neurotransmitter involved in the reward pathway in
the brain, which is made possible in part by the euphoric effects of dopamine (Dunlop &
Nemeroff, 2007). Illegal substances and prescription drugs with high addiction potential work
through the same reward pathway. Some drugs, like prescription medications, inhibit the
dopamine transporter (Mishra et. al, 2018), which is the protein responsible for removing
dopamine from the neural synapse.
Caffeine specifically increases dopamine signaling in the brain by increasing dopamine
receptor availability (Volkow et. al, 2015). Caffeine has been found to increase the availability of
D2 and D3 receptors in the putamen and ventral striatum (Volkow et. al, 2015). Studies have
shown that increases in D2 and D3 receptor availability in the ventral striatum, caused by
ingesting caffeine, are what temporarily increase alertness in caffeine-consuming individuals
(Volkow et. al, 2015). By increasing the availability of these dopamine receptors, more
dopamine can bind to receptors, which then increases dopaminergic signaling in the brain, thus
increasing the overall effect of dopamine (Mishra et. al, 2018). However, these effects of
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increased dopamine are only temporary. Over time, with long-term consumption of caffeine, the
brain will stop producing as much dopamine as normal (Mishra et. al, 2018). Instead, it begins to
compensate, relying on increasing amounts of caffeine to achieve normal amounts of dopamine
and dopaminergic signaling. As a result, caffeine withdrawal symptoms occur, such as tiredness,
fatigue, and irritability.
Methods
A literature review was conducted using the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA). The databases searched were Medline, CINAHL
Complete, and PsychInfo. An article search was completed from the years 2014 to 2020. The
terms, “caffeine AND addiction or withdrawal or stop” were used, which yielded 430 research
articles. To limit the population to adults, the results were further narrowed by adding the terms,
“NOT child or adolescent,” which yielded 366 results. By adding the terms, “NOT rat or rodents
or mice or animal and NOT alcohol or nicotine,” the search was narrowed one final time to
exclude all studies on animals, and all articles that examined caffeine use along with alcohol or
nicotine use. One hundred forty-six articles remained, and once duplicates were removed the
article list decreased to 134. After title and abstract review, 115 articles were excluded for not
meeting the purpose of the review. Articles that solely discussed caffeine side effects, caffeine
use, or caffeine consumption were eliminated. Nineteen full-text articles were assessed for
eligibility. Articles included directly examined methods to decrease or stop caffeine intake and
improve caffeine withdrawal symptoms. In total, seven articles met the inclusion criteria for this
review (See Figure 1 and Appendix A).
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Results

Using an Instructional Manual with or without a Counselor
Two studies examined the effectiveness of using an instructional manual to help caffeinedependent patients abstain. The manual contained information such as a list of caffeine content
in various food and drinks, general information about caffeine, behavioral strategies to decrease
caffeine intake, and a journal with a graph for patients to record their daily caffeine intake. One
study provided only the manual to participants while the other included the manual and a 60minute counseling session (Evatt et al., 2016; Sweeney et al., 2019). During the counseling
session, the counselor taught participants about caffeine dependence, withdrawal symptoms, and
coping strategies to overcome stress and the desire to consume caffeine (Evatt et al., 2016). The
participants in both studies recorded daily caffeine intake in a journal during and after the study
(Sweeney et al., 2019). Both studies had participants gradually decrease caffeine intake in order
to minimize withdrawal effects (Sweeney et al., 2019). The first study instructed patients to taper
their caffeine consumption to 75% of their normal caffeine in the first week, 50% in their second
week, 25% during the third week, 12.5% during the fourth week, and to as little as possible the
fifth week (Evatt et al., 2016). The second study did not specify the exact details of the caffeine
taper but gave the participants the general information on how to taper in the manual (Sweeney
et al., 2019).
Both studies found the caffeine taper and instructional manual to be effective in reducing
or eliminating caffeine intake up to the 1-year mark. Both found journaling to be helpful in
reducing caffeine intake. The session with the counselor also was successful in reducing
caffeine intake. Those who had a session with a counselor on average reduced their caffeine by
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slightly more (77% reduction) than those who did not meet with a counselor (75% reduction), up
to a year afterwards (Sweeney et al., 2019).
The Role of Placebo in Reducing Withdrawal Symptoms
The role of using placebo caffeine to help manage caffeine withdrawal symptoms was
also studied. One study evaluated 89 adults, who self-identified as moderate to heavy coffee
drinkers (Mills et al., 2016). The participants were required to drink three cups of coffee in a 24
hour period, and then go 24 hours without any caffeine intake. After 24 hours without caffeine
intake the participants blood pressure was measured, and they completed the Caffeine
Withdrawal Symptom Questionnaire (CWSQ) test to assess their withdrawal symptoms. The
CWSQ test measures symptoms such as fatigue, mood disturbances, personal motivation,
nausea, and headache. A low score indicates mild withdrawal symptoms, while a high score
indicates more intense withdrawal symptoms. Patients completing the questionnaire then drank a
cup of decaffeinated coffee. Half the group was told the coffee was decaffeinated, and half was
told the coffee was caffeinated. After 45 minutes, participants had their blood pressure measured,
and completed the CWSQ. Participants who believed they drank caffeinated coffee had a
reduction of 14.6 points on the CWSQ test after drinking the beverage, while the group believing
they drank decaffeinated coffee had only a 5.5-point reduction (Mills et al., 2016). There was no
statistically significant change in blood pressure in either group (Mills et al., 2016).
In another study, the effect of caffeine content on withdrawal symptoms was evaluated
(Mills et al., 2017). The researchers found that patients who believed they were drinking caffeine
when they were actually not, reported a lower CWSQ score than those who knew they were
consuming a decaffeinated drink. These findings were validated by Juliano et al. (2019) who
discovered participants who believed they were drinking caffeine when actually given a
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decaffeinated drink experienced less withdrawal symptoms than those who knew they were
consuming a decaffeinated beverage (Juliano et al., 2019).
False Genetic Information
The effect of genetic counseling and false genetic information on caffeine withdrawal
symptoms has been studied. One study analyzed how withdrawal response during cessation of
caffeine is affected when a participant is told they have a certain gene related to caffeine
withdrawal (Mills et al., 2017). Ninety-three caffeine users were tested with a false DNA test,
which was obtained through a swab of the cheek. The participants then met with a researcher
who informed them that the presence of a specific allele on the dopamine receptor gene had been
found to greatly increase caffeine withdrawal symptoms. Three days later, the participants were
called with their false genetic test results and were told whether they tested positive or negative
for the gene. The participants were again informed of the effects of this gene on caffeine
withdrawal. Those told they tested positive for the gene were warned they may be more
susceptible to intense caffeine withdrawal symptoms. Then participants were instructed to go for
24 hours without caffeine and measure their withdrawal symptoms on a self-reported caffeine
withdrawal scale. After the 24-hour period, participants were instructed to drink a cup of coffee
and report their withdrawal symptoms again. The Post-Beverage and Pre-Beverage CWSQ
scores were compared, and the differences were not statistically significant (χ2 (1) = 0.18,
p = 0.671) (Mills et al., 2017). Overall, the false genetic information had no effect on caffeine
withdrawal symptoms.
Blinded Dose Taper
One study aimed to test the effect of a blinded dose taper on caffeine withdrawal effects.
In this study, three groups of caffeine-dependent participants had their daily intake of caffeine
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gradually decreased from 300mg per day to 0mg during a 4-day period (Mills et al., 2018). The
first day the participants were given 300mg of caffeine, the second day 200mg, the third day
100mg, and the fourth day 0mg. Participants in the designated “open reduction group” knew how
much caffeine they received. Participants in the blinded group were not given any information
regarding the amount of caffeine they received. A third group was designated “the deceptive
group,” and were given inaccurate information regarding their caffeine intake. Twice daily, all
study participants completed the CWSQ test to monitor their withdrawal symptoms. The test was
completed in the morning and afternoon. In the morning, there was no significant difference in
the CWSQ scores between the three groups (Mills et al., 2018). However, in the afternoon, the
open reduction group experienced a mean increase of 6.95 points on the CWSQ test per day, the
deceptive reduction group increased by 2.12 points per day, and the blinded group increased by
2.73 points per day (Mills et al., 2018). According to these data, the caffeine dose information
reported to participants greatly influenced their withdrawal symptoms. The deceptive group was
told their caffeine was decreased by a lot less than it actually was, and they reported the least
amount of caffeine withdrawal symptoms.
Aerobic Exercise
One study examined the effect of aerobic exercise on caffeine withdrawal. In the study,
caffeine-dependent participants consumed no caffeine for 12 hours. After consuming no caffeine
for 12 hours, the participants’ CWSQ scores increased by an average of 14.88 points from
baseline (Morava et al., 2019). The participants were randomly assigned to either consume
caffeine or exercise by briskly walking for 20 minutes. The participants in the caffeine
consumption group had a mean reduction of 12.91 points on the CWSQ after ingesting caffeine.
The exercise group had a mean reduction of 8.07 points on the CWSQ test (Morava et al., 2019).
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These results support the assertion that brisk exercise has utility in reducing caffeine withdrawal
symptoms. Specifically, the participants indicated that the exercise gave them extra energy, put
them in a better mood, and increased their alertness. The exercise participants also showed a
short-term increase in their working memory (Morava et al., 2019).
Discussion
Nurse practitioners should routinely assess a patient’s caffeine usage as well as any desire
to discontinue caffeine ingestion, which is especially important if caffeine use is problematic,
contraindicated, or causing unwanted side effects. Patients should be educated regarding the
withdrawal effects of caffeine, as well as the health benefits of discontinuing caffeine. Benefits
to quitting caffeine include increased energy, less fatigue, better sleep at night, less headaches,
less irritability, and better focus.
Although the use of a placebo and false genetic information in mitigating caffeine
withdrawal symptoms have been studied and included in this literature review, this specific
information may not be helpful to a nurse practitioner, as it would be difficult to apply in a
clinical setting. It also would not be ethical for a nurse practitioner to mislead a patient by using
placebos or false genetic information.
Tapering Caffeine Intake
One strategy identified in quitting caffeine use while decreasing caffeine withdrawal
symptoms is to gradually decrease caffeine intake. One study found it effective for participants
to consume 75% of their normal caffeine in the first week, 50% in the second week, 25% during
the third week, 12.5% during the fourth week, and as little as possible the fifth week (Evatt et al.,
2016). This strategy could easily be implemented in a clinical setting.
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Keeping a Daily Record of Caffeine Use
Another strategy identified to assist in quitting caffeine use is to keep a daily record of
caffeine intake. This is something that could easily be implemented by a nurse practitioner.
Nurse practitioners can encourage patients wanting to quit caffeine to keep a daily journal of
their ingested caffeine. The patient may also record how they felt, how they slept, any
withdrawal effects, and any stressors in their life. If significant issues are noted via journaling,
the nurse practitioner could then teach coping strategies, or refer the patient for counseling in an
attempt to resolve the identified problems.
Symptom Reduction
There are several strategies nurse practitioners can recommend to reduce caffeine
withdrawal symptoms. Exercise is one effective strategy to help reduce caffeine withdrawal
symptoms (Morava et al., 2019). Specifically, briskly walking for 20 minutes was associated
with a lower CWSQ score, and was found to increase participants alertness and energy. In
addition, it put participants in a better mood, and increased their short-term memory. Daily
exercise should be recommended while a patient is tapering caffeine use in an attempt to mitigate
withdrawal symptoms. Other helpful interventions may include over-the-counter pain
medications for headaches, instruction regarding sleep hygiene, and a prescription for short-term
anti-nausea medication.
Additional Resources
This literature review also identified several resources a nurse practitioner can provide to
their patients in their efforts to quit or reduce caffeine consumption. A nurse practitioner can give
their patient a manual or handout with information about how to reduce caffeine intake, what
withdrawal symptoms to expect, and strategies to help reduce caffeine intake. In addition, a
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nurse practitioner can recommend a patient start seeing a counselor to help with any underlying
issues that may contribute to caffeine intake.
Conclusion
The purpose of this review was to identify strategies for decreasing caffeine dependence
or reducing caffeine intake, and minimizing withdrawal symptoms while doing so. Based on
research findings, several strategies were identified. Exercise helps in reducing caffeine
withdrawal symptoms. Using a gradual caffeine dose taper is successful in helping people quit
caffeine or reduce their caffeine intake, while simultaneously mitigating withdrawal symptoms.
Meeting with a counselor to discuss ways to overcome the temptation to use caffeine, as well as
providing individuals with a written manual with information about caffeine has proven effective
in reducing caffeine consumption. Keeping a journal of caffeine intake, and having participants
continue to record their caffeine intake after treatment is associated with long-term success in
quitting caffeine.
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Appendix A
Citation

Design

Purpose of the Study

Sample
Size

Methods

Results

(Evatt et al.,
2016)

Randomized
Control Trial

The purpose of this study was
to develop and test a therapistguided manualized treatment
for caffeine use including
cognitive-behavioral therapy
and five weeks of gradually
tapering down caffeine
consumption.

67

Individuals seeking treatment for problematic
caffeine use were randomized using a waitlistcontrol design to receive immediate treatment or
delayed treatment, which was six weeks later. A
one-hour long treatment session designed to help
individuals quit or reduce caffeine consumption
was provided by a trained counselor along with a
take-home booklet. After the treatment session,
participants completed daily diaries of caffeine
consumption for 5 weeks. They returned for followup assessments at 6, 12, and 26 weeks and had a
telephone interview at 52-weeks post-treatment.

Treatment resulted in a significant
reduction in self-reported caffeine use
and salivary caffeine levels. No
significant posttreatment increases in
caffeine use were observed for up to 1year follow-up. Comparisons to the
waitlist-control condition revealed that
reductions in caffeine consumption
were due to treatment and not the
passing of time.

(Morava et
al., 2019)

Quasiexperimental
experiment

The purpose of this study was
to compare the effects of acute
moderate intensity aerobic
exercise to caffeine on working
memory and caffeine
withdrawal symptoms.

59

There were two phases to this study. In phase one,
non-caffeine and caffeine consumers completed a
working memory assessment, followed by acute
exercise and caffeine intake. In Phase II, caffeine
consumers from Phase I underwent the working
memory assessment and reported caffeine
withdrawal symptoms following a 12-hour
deprivation period

Twenty minutes of acute aerobic
exercise was effective in decreasing
caffeine withdrawal symptoms.

The purpose of this study was
to examine the usefulness of a
manual-only treatment
program for caffeine cessation
and reduction among
individuals seeking treatment
for problematic caffeine use.

36

Individuals were randomly assigned to receive
either immediate treatment or treatment delayed by
7 weeks. The treatment consisted of a manual
containing information about caffeine and
instructions for gradually reducing caffeine
consumption over a period of 6 weeks, with no
counseling or additional support. Caffeine
consumption and caffeine-related distress were
assessed before treatment, 7 weeks after receiving
the treatment manual (end-of-treatment), and 20
weeks post-treatment.

The manual-only treatment resulted in
significant reductions in participants’
self-reported caffeine consumption and
caffeine-related distress at end-oftreatment that were sustained at 20weeks post-treatment. Comparisons
between the immediate and delayed
treatment groups suggest the reductions
in caffeine consumption were
attributable to the manualized treatment
rather than spontaneous with the
passage of time.

(Sweeney et
al., 2019)

Randomized
control trial

Exercise and caffeine administration
improved working memory accuracy in
caffeine and non-caffeine consumers.
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2 × 2 × (2)
mixed design

15

The purpose of this study was
to test the effect of genetic
information and information
about the caffeine content of a
beverage on caffeine
withdrawal, specifically if: (1)
being informed that one has
tested positive for a gene
related to caffeine withdrawal
can produce an exaggerated
caffeine withdrawal response
during abstinence; (2) belief
that one has consumed caffeine
leads to a reduction in
withdrawal symptoms when no
caffeine is consumed.

93

There were two two-level, between-subject factors:
Priming (Gene positive or Gene negative
conditions) and Caffeine Information (Told
Caffeine or Told Decaf condition). The two-level
within-subjects factor was time, with one
measurement being taken after 24 hours without
consuming caffeine (Pre-Beverage) and the other
being taken 45 minutes after a cup of decaffeinated
coffee (Post-Beverage). The outcome of interest
was self-reported caffeine withdrawal symptoms.

Participants given decaffeinated coffee
who were allowed to believe they had
consumed caffeinated coffee showed a
significantly greater reduction in
reported caffeine withdrawal symptoms
than participants who knew they had
been given decaffeinated coffee.
The genetic information had no effect
on caffeine withdrawal symptoms.

(Juliano et
al., 2019)

2 by 2
balanced
placebo design

The purpose of this study was
to investigate psychological
influences on drug withdrawal
symptomatology using a
caffeine‐based model.

87

Using the 2 × 2 balanced placebo design caffeine
dose (given caffeinated vs decaffeinated coffee)
was crossed with dose expectancy (told caffeine vs.
decaf) among 87 (16‐hr abstinent) regular coffee
consumers in a 2‐day study, in order to test caffeine
cravings and withdrawal symptoms.

Participants in the decaf group reported
greater caffeine cravings than those in
the told caffeine both 45 minutes and 8
hour post manipulation. Those given
decaf reported greater withdrawal
symptoms and showed poorer cognitive
performance both 45 minutes and 8
hour post manipulation, with effects for
headache and flu‐like symptoms first
emerging 8 hour post manipulation.
Giving the participants caffeine
alleviated all withdrawal symptoms and
cognitive decrements within 45
minutes.

(Mills et al.,
2018)

A mixed
between- and
withinsubjects
design.

The purpose of this study was
to test whether blinding
participants to caffeine dose
reductions leads to less severe
withdrawal symptoms

48

Three groups of coffee drinkers had their dose of
caffeine tapered from 300 mg per day to 0 mg over
the course of five days and reported withdrawal
symptoms twice daily. Groups were given different
information about how much caffeine they were
receiving. An Open Reduction group was given
accurate information about dose reductions. A
Blind Reduction group was given no dose
information whatsoever. A Deceptive Reduction

The Open Reduction group reported
more intense caffeine withdrawal
symptoms than the Deceptive
Reduction group on the days with the
greatest discrepancy between actual
dose and informed dose, indicating a
nocebo effect of open versus deceptive
reductions. In addition, the rate of
increase in intensity of reported
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2 by 2 mixed
design

The purpose of the study was
to use caffeine as a model to
test the effect of expectancy on
withdrawal symptoms,
specifically whether the belief
that one has ingested caffeine
is sufficient to reduce caffeine
withdrawal symptoms and
cravings in abstinent coffee
drinkers.

16

89

group was misinformed about the dose, with
instructions suggesting that the dose remained on
300 mg for three days then dropped to 0 mg.

withdrawal symptoms in the Blind
Reduction and Deceptive Reduction
groups was less than that of the Open
Reduction group.

24 hour abstinent regular coffee drinkers completed
the caffeine withdrawal symptom questionnaire
(CWSQ) before and after receiving decaffeinated
coffee. One half of the participants were led to
believe the coffee was regular caffeinated coffee
(the ‘Told Caffeine’ condition) and one half were
told that it was decaffeinated (the ‘Told Decaf’
condition).

Participants in the Told Caffeine
condition reported a significantly
greater reduction in the factors of
cravings, fatigue, lack of alertness and
flu-like feelings of the CWSQ, than
those in the Told Decaf condition.
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Figure 1

Screening

Identification

PRISMA Flow Diagram

Records identified through
database searching
(n = 146)
12 articles removed for duplication

Records screened
(n = 134)
115 records excluded after
title and abstract review

Eligibility

Full-text articles assessed
for eligibility
(n = 19)

Included

Studies included in
synthesis
(n = 7)

12 Full-text articles
excluded for solely
discussing caffeine side
effects, caffeine use, or
caffeine consumption

